Sign Up | Log In | What is SocialPicks?

Investment Ideas Served Daily By People You Trust

SocialPicks is a community where stock investors exchange ideas and track performance of financial bloggers.

Are you a stock guru?

Share picks & earn reputation

Mike Havrilla www.BioRunUp.com

Start Tracking Mike Havrilla - Add to Friends - Send Message

Community Rank: Principal (7000 pts) | Member since 07/15/2008

Picks Performance:

Outperforms

73%

of community

What's this?

All-time Return +1.04% (in over 4 years)	Risk (SD) Moderate 0.00%	Sharpe Ratio -2.09
Followers 87	Winning Picks 786 of 1807	Total Views 2576118

Overview

Stocks

Stats

Community

Widget

Shared Picks | Personal Portfolio | Voted Picks | Commented On

View: Shared Picks (Quick) / (Detailed) | Personal Portfolio

Open | Closed

Symbol	SP Sentiment	Date	Return	Market	v.s. Market	Title	Pts
FRX		07/06/10	+44.49%	+0.00%	+44.49%	Trading FDA, Clinical Trial Binary Events..	9
ASTM		06/22/10	-63.85%	+0.00%	-63.85%	FDA, Clinical Trial Extreme Trades: $ASTM..	9
IYT		06/05/10	+47.55%	+0.00%	+47.55%	FDA, Clinical Trial Stocks and Healthcare..	9
UNG		06/05/10	+146.09%	+0.00%	+146.09%	FDA, Clinical Trial Stocks and Healthcare..	9
BTI		05/22/10	+90.08%	+0.00%	+90.08%	FDA Panel to Review Menthol Cigarettes, D..	9
ABT		05/22/10	-22.37%	+0.00%	-22.37%	Abbott Expands Emerging Market Generic Dr..	9
JAV		05/20/10	n/a	+0.00%	n/a	FDA, Clinical Trial News: Discovery Labs,..	9
TEVA		05/15/10	-31.20%	+0.00%	-31.20%	Abbott Deal Highlights Growth Prospects f..	9
AMTD		05/08/10	+28.69%	+0.00%	+28.69%	Personalized Stock Index Investing at Inv..	9
CLDX	N/A	04/29/10	+103.34%	+0.00%	+103.34%	Dendreon’s Provenge FDA Approval Lifts ..	9
PVCT	N/A	04/29/10	n/a	+0.00%	n/a	FDA, Clinical Trial News: Pozen, Provectu..	1
NVAX		04/29/10	-34.81%	+0.00%	-34.81%	FDA, Clinical Trial News: Pozen, Provectu..	9
EDAP	N/A	04/26/10	+5.25%	+0.00%	+5.25%	FDA, Clinical Trial News: NexMed, EDAP	9
XLV		04/25/10	+52.73%	+0.00%	+52.73%	New Free and Premium Features at mikehavR..	9
ACUR	N/A	04/22/10	+63.39%	+0.00%	+63.39%	FDA, Clinical Trial News: Acura / King Ph..	9
AMLN		04/22/10	n/a	+0.00%	n/a	FDA, Clinical Trial News: Acura / King Ph..	9
GENZ		04/21/10	n/a	+0.00%	n/a	FDA, Clinical Trial News: Delcath, Genzym..	9
DCTH		04/21/10	-96.08%	+0.00%	-96.08%	FDA, Clinical Trial News: Delcath, Genzym..	9
CADX	N/A	04/19/10	-30.87%	+0.00%	-30.87%	FDA, Clinical Trial News: Prana Biotech, ..	9
OSIP	N/A	04/17/10	n/a	+0.00%	n/a	FDA, Clinical Trial News: Approvals for O..	9

« previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
next »

Open | Closed

Symbol	SP Sentiment	Date	Return	Market	v.s. Market	Title	Pts
OREX	N/A	07/21/09	-42.42%	+0.00%	-42.42%	FDA Calendar: Five Weight Loss Trades	9
VVUS		07/08/10	+9.56%	+0.00%	+9.56%	Trading FDA, Clinical Trial Binary Events..	9
VVUS		09/18/09	-8.25%	+0.00%	-8.25%	BioMed News Bytes: Arena (NASDAQ: ARNA), ..	9
XNPT		11/13/08	-78.72%	+0.00%	-78.72%	Updated FDA Calendar of Decision Dates	9
IBB		06/23/10	-6.73%	+0.00%	-6.73%	Trading FDA, Clinical Trial Binary Events..	8
FRX		04/08/10	+15.31%	+0.00%	+15.31%	FDA, Clinical Trial News: $FRX $HTWR $DRR..	9
IBB		06/20/10	-2.66%	+0.00%	-2.66%	Trading FDA, Clinical Trial Binary Events..	9
ASTM		01/23/09	+111.76%	+0.00%	+111.76%	Index to Track New Era for Stem Cell Cos...	1
IBB		06/16/10	+0.59%	+0.00%	+0.59%	Trading FDA, Clinical Trial Binary Events..	9
IBB		06/12/10	+2.02%	+0.00%	+2.02%	Tracking FDA, Clinical Trial Binary Event..	9
IBB		06/05/10	+1.22%	+0.00%	+1.22%	FDA, Clinical Trial Stocks and Healthcare..	9
IYT		04/23/10	-11.88%	+0.00%	-11.88%	Event Calendar Tracking Added for mikehav..	9
UNG		01/22/09	-56.95%	+0.00%	-56.95%	1-Year Analysis of Coal Price vs. Energy ..	9
IBB		06/01/10	+0.70%	+0.00%	+0.70%	History of Success Trading FDA Catalyst E..	9
IBB		05/16/10	-6.43%	+0.00%	-6.43%	Near-Term FDA, Clinical Trial Extreme Tra..	9
BTI		10/22/08	+18.97%	+0.00%	+18.97%	Expanding Defensive Growth Index into Eur..	9
ABT		05/15/10	-3.22%	+0.00%	-3.22%	Abbott Deal Highlights Growth Prospects f..	10
JAV		08/01/09	-4.21%	+0.00%	-4.21%	FDA Calendar Extreme Trades: 30 Stocks Un..	9
IBB		05/08/10	+3.19%	+0.00%	+3.19%	Personalized Stock Index Investing at Inv..	9
TEVA		03/23/10	-11.99%	+0.00%	-11.99%	HavRx Stock Indexes: Healthcare Continues..	9

« previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
next »

Similarity to Me ?

Compare Your Portfolio With Mike Havrilla: Enter stocks you like & track your portfolio:

Symbols, separated by space (e.g. AAPL GOOG MSFT)

More about Mike Havrilla

Investment Style:
Aggressive [?]

Avg exp holding time:
384.53 days

Age: 30's
Location: USA

Website:
www.BioRunUp.com

About Me:

I am a pharmacist, writer, marathon runner, and investor. Check out the Ultimate Guide to Biotech Sto ... more

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.